Headquartered in Singapore, we aim to become the leading company in medical technology innovations in the Asia Pacific region. We leverage on our extensive regional commercialisation network in Asia Pacific to drive market adoption and accelerate growth.
The strategising and development of this platform started 10 years ago with the aim of establishing a holistic and strong infrastructure for the new era of medical technologies market.
At ZIG Medtech Asia, our mission is to bring innovative healthcare products to the Asia Pacific region and beyond.
It takes immense amount of time, effort and resources to penetrate any market and get commercial adoption for new medical technologies. ZMA has forged commercial partnerships in key markets in APAC.
ZMA will serve as a launch pad, assisting with pre-market activities, regulatory approvals, setting up sales network in targeted markets and providing aftersales support. Companies only have to plug into ZMA through one of the business collaboration models available that fit their needs and purpose.
ZIG Medtech Asia is a subsidiary of ZIG Ventures, an investment holding company of the healthcare biomedical and sciences technologies businesses.
Our Core Values
Pursuit Of Excellence
Always putting the Customer First
We accelerate sales growth through direct sales force or strong alliances of distribution network in Asia Pacific.
- Hong Kong
- South Korea
Meet Our Team
Kok Hwee has a Masters of Science Degree in Financial Engineering from Columbia University, New York, USA and a Bachelor of Science Degree in Industrial and Operations Research from the University of Michigan, Ann Arbor, USA (Magna Cum Laude).
Lai Leng holds a doctorate degree in Biochemistry from the Faculty of Medicine, National University of Singapore. She has undergone executive development training programs in leadership communications in Singapore Management University as well as intellectual property law in the Faculty of Law, National University of Singapore.
As the Medical Affairs Manager with AstraZeneca, Lai Chee was the reviewer and approver of all pharmaceutical promotional material produced for the Singapore and Malaysia market. She also conducted training to doctors on the technique of administering AstraZeneca’s Marcaine® Spinal Injection.
Lai Chee is a registered pharmacist and qualified ISO 13485 Lead External Auditor.
Our clients say
Here are some of our clients’ experience and feedback from working with us.
“ZMA has been very supportive and has helped us to get our products into the SEA market as quickly as possible.””Dr Helen KimGeneral Manager, C&R Healthcare Global Pte.Ltd.